Jill Schinkel, MS

Director, Health Economics and Outcomes Research
Inovalon

Poster(s):

• (382) A claims-based analysis of the real-world economic burden of illness in patients with Sjögren’s disease in the United States
  Wednesday, October 29, 2025

• (408) Reduction in Asthma Exacerbations Following Initiation of Benralizumab Among Medicare Beneficiaries: Results from the ZEPHYR-5 Study
  Wednesday, October 29, 2025